Skip to main content
User account menu
Log in
X
Main navigation
About
Advisory Boards
Leadership
Steering Committee
News & Announcements
Messages from Our Leaders and Colleagues
Press Releases
HIV in the News
Events & Training
Grants & Funding
People
Email Groups
Publications
Resources
Search
Home
News & Announcements
HIV / AIDS in the News
Methodology – 2024 State of HIV Stigma Report - GLAAD
Thursday, September 12 2024 - 9:56
Introduction – 2024 State of HIV Stigma Report - GLAAD
Thursday, September 12 2024 - 9:56
HIV Stigma Spotlight – 2024 State of HIV Stigma Report - GLAAD
Thursday, September 12 2024 - 9:55
Key Findings – 2024 State of HIV Stigma Report - GLAAD
Thursday, September 12 2024 - 9:54
GLAAD RELEASES 5th STATE OF HIV STIGMA REPORT - GLAAD
Thursday, September 12 2024 - 9:52
GLAAD releases 2024 State of HIV Stigma report - Windy City Times
Thursday, September 12 2024 - 9:52
Gilead says HIV prevention injection reduced cases by 96%, sending shares higher - Investing.com
Thursday, September 12 2024 - 9:41
Helping End HIV - Gilead Sciences - Yahoo Finance
Thursday, September 12 2024 - 9:35
Helping End HIV - Gilead Sciences - StockTitan
Thursday, September 12 2024 - 9:35
HIV patients who lose short-term financial incentives to receive care don’t fare worse after payments cease - UC Berkeley School of Public Health
Thursday, September 12 2024 - 9:00
Twice-a-year injection reduced risk of HIV infection by 96%, drug company says — more than daily PrEP pill - CNN
Thursday, September 12 2024 - 8:48
Gilead Stock Jumps After It Unveils More Positive Data on HIV Prevention Shot - Barron's
Thursday, September 12 2024 - 8:44
Gilead announces PURPOSE 2 met efficacy endpoints, reduced HIV infections by 96% - TipRanks
Thursday, September 12 2024 - 8:43
Gilead’s twice-yearly antiviral protects against HIV infection in second large trial - STAT
Thursday, September 12 2024 - 8:40
Gilead's (GILD) Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada - StreetInsider.com
Thursday, September 12 2024 - 8:31
Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada® in Second Pivotal Phase 3 Trial - StockTitan
Thursday, September 12 2024 - 8:30
Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada® in Second Pivotal Phase 3 Trial - Business Wire
Thursday, September 12 2024 - 8:30
'Sorry, but we won't be treating you' - BBC.com
Thursday, September 12 2024 - 7:08
Shelby County, a hotspot for HIV, forfeited $3M in federal HIV funding - Tennessee Lookout
Thursday, September 12 2024 - 6:04
Gilead says its twice-yearly shot cut HIV infections by 96% in trial - CNBC
Thursday, September 12 2024 - 3:00
IVF in Ireland: HIV-positive woman calls for change - BBC.com
Thursday, September 12 2024 - 3:00
An injectable HIV-prevention drug is highly effective — but wildly expensive - NBC News
Thursday, September 12 2024 - 3:00
HIV Advocate & Former Mardi Gras President Bill Whittaker Has Passed Away - Star Observer
Thursday, September 12 2024 - 1:43
AIDS Lifecyle Ride to end come 2025 amid fundriaising issues - NBC Bay Area
Wednesday, September 11 2024 - 22:54
Antidiabetic Drug Metformin Could Help Immune System Recognize HIV - Managed Healthcare Executive
Wednesday, September 11 2024 - 16:22
CDC in Brazil - CDC
Wednesday, September 11 2024 - 15:11
Older Adults & HIV | Social Media Toolkits | Partner With Us | Let's Stop HIV Together - CDC
Wednesday, September 11 2024 - 15:10
SARS-CoV-2 Rapidly Evolves in People with Advanced HIV - POZ
Wednesday, September 11 2024 - 14:33
How Metformin May Help Fight HIV - DocWire News
Wednesday, September 11 2024 - 12:16
Pneumocystis jirovecii Pneumonia and HIV-Associated Nephropathy in Acute HIV Infection - Cureus
Wednesday, September 11 2024 - 11:29
Pagination
First page
« First
Previous page
‹‹
…
Page
40
Page
41
Page
42
Page
43
Current page
44
Page
45
Page
46
Page
47
Page
48
…
Next page
››
Last page
Last »